Grant R. Goodman

1.1k total citations
16 papers, 552 citations indexed

About

Grant R. Goodman is a scholar working on Oncology, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, Grant R. Goodman has authored 16 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in Grant R. Goodman's work include Bone health and treatments (5 papers), Melanoma and MAPK Pathways (5 papers) and Bone and Joint Diseases (4 papers). Grant R. Goodman is often cited by papers focused on Bone health and treatments (5 papers), Melanoma and MAPK Pathways (5 papers) and Bone and Joint Diseases (4 papers). Grant R. Goodman collaborates with scholars based in United States, Australia and Italy. Grant R. Goodman's co-authors include Alan Saven, James A. Koziol, Carol Burian, W.S.S. Jee, Kelly Bethel, Andrew R. Bowman, Solomon Epstein, Sol Epstein, S Pun and Y.F. Ma and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Bone and Mineral Research.

In The Last Decade

Grant R. Goodman

16 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grant R. Goodman United States 12 246 236 161 158 130 16 552
Silvana Capalbo Italy 15 271 1.1× 166 0.7× 143 0.9× 179 1.1× 144 1.1× 37 669
Shigeki Fujita Japan 13 194 0.8× 308 1.3× 359 2.2× 68 0.4× 81 0.6× 30 592
Maitrayee Goswami United States 16 304 1.2× 165 0.7× 149 0.9× 62 0.4× 191 1.5× 31 735
Jean Michel Picquenot France 8 68 0.3× 264 1.1× 318 2.0× 111 0.7× 74 0.6× 11 598
T. P. Vassilakopoulos Greece 12 166 0.7× 160 0.7× 271 1.7× 81 0.5× 108 0.8× 19 502
E. S. Henderson United States 13 316 1.3× 118 0.5× 191 1.2× 142 0.9× 79 0.6× 21 615
R. Besuyen United States 13 95 0.4× 141 0.6× 55 0.3× 271 1.7× 36 0.3× 41 692
László Váróczy Hungary 13 127 0.5× 85 0.4× 223 1.4× 89 0.6× 56 0.4× 47 425
Alex Freire Sandes Brazil 11 162 0.7× 92 0.4× 117 0.7× 118 0.7× 76 0.6× 35 415
Leonie Saft Sweden 16 405 1.6× 118 0.5× 148 0.9× 109 0.7× 298 2.3× 37 1.1k

Countries citing papers authored by Grant R. Goodman

Since Specialization
Citations

This map shows the geographic impact of Grant R. Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant R. Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant R. Goodman more than expected).

Fields of papers citing papers by Grant R. Goodman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant R. Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant R. Goodman. The network helps show where Grant R. Goodman may publish in the future.

Co-authorship network of co-authors of Grant R. Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Grant R. Goodman. A scholar is included among the top collaborators of Grant R. Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant R. Goodman. Grant R. Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
Barteselli, Giulio, et al.. (2022). Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies. Drug Safety. 45(12). 1491–1499. 2 indexed citations
4.
Ascierto, Paolo A., Karl D. Lewis, Anna Maria Di Giacomo, et al.. (2020). Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation–positive melanoma receiving adjuvant vemurafenib. Annals of Oncology. 31(1). 153–159. 29 indexed citations
5.
Zhang, Weijiang, Michael S. Mathisen, Grant R. Goodman, et al.. (2020). Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady‐State Pharmacokinetics of Vemurafenib in Patients With BRAFV600 Mutation–Positive Malignancies. Clinical Pharmacology in Drug Development. 10(1). 39–45. 3 indexed citations
6.
Schadendorf, Dirk, Anna Maria Di Giacomo, Lev Demidov, et al.. (2019). Health-related quality of life in patients with fully resected BRAFV600 mutation–positive melanoma receiving adjuvant vemurafenib. European Journal of Cancer. 123. 155–161. 3 indexed citations
7.
Lewis, Karl D., Michele Maio, Mario Mandalà, et al.. (2014). BRIM8: A phase III, randomized, double-blind, placebo-controlled study of vemurafenib adjuvant therapy in patients with surgically resected, cutaneous BRAF-mutant melanoma at high risk for recurrence (NCT01667419).. Journal of Clinical Oncology. 32(15_suppl). TPS9118–TPS9118. 3 indexed citations
8.
Goodman, Grant R., Ernest Beutler, & Alan Saven. (2003). Cladribine in the treatment of hairy-cell leukaemia. Best Practice & Research Clinical Haematology. 16(1). 101–116. 27 indexed citations
9.
Goodman, Grant R., Kelly Bethel, & Alan Saven. (2003). Hairy cell leukemia: an update. Current Opinion in Hematology. 10(4). 258–266. 54 indexed citations
10.
Goodman, Grant R., Carol Burian, James A. Koziol, & Alan Saven. (2003). Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine. Journal of Clinical Oncology. 21(5). 891–896. 196 indexed citations
11.
Epstein, Sol, Grant R. Goodman, Andrew R. Bowman, et al.. (2001). Effect of the Interaction of Parathyroid Hormone and Cyclosporine A on Bone Mineral Metabolism in the Rat. Calcified Tissue International. 68(4). 240–247. 36 indexed citations
12.
Goodman, Grant R., Andrew R. Bowman, S Pun, et al.. (2001). Transforming growth factor-β administration modifies cyclosporine A-induced bone loss. Bone. 28(6). 583–588. 14 indexed citations
13.
Goodman, Grant R., et al.. (2001). Immunosuppressant Use Without Bone Loss—Implications for Bone Loss After Transplantation. Journal of Bone and Mineral Research. 16(1). 72–78. 42 indexed citations
14.
Goodman, Grant R., et al.. (1999). Interferon-α, unlike interferon-γ, does not cause bone loss in the rat. Bone. 25(4). 459–463. 19 indexed citations
15.
Epstein, Sol & Grant R. Goodman. (1999). Improved Strategies for Diagnosis and Treatment of Osteoporosis. Menopause The Journal of The North American Menopause Society. 6(3). 242–250. 15 indexed citations
16.
Goodman, Grant R., et al.. (1998). MYCOPHENOLATE MOFETIL: A PROMISING NEW IMMUNOSUPPRESSANT THAT DOES NOT CAUSE BONE LOSS IN THE RAT1,2. Transplantation. 65(2). 275–278. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvana Capalbo Breakdown of academic impact, for papers by Shigeki Fujita Breakdown of academic impact, for papers by Maitrayee Goswami Breakdown of academic impact, for papers by Jean Michel Picquenot Breakdown of academic impact, for papers by T. P. Vassilakopoulos Breakdown of academic impact, for papers by E. S. Henderson Breakdown of academic impact, for papers by R. Besuyen Breakdown of academic impact, for papers by László Váróczy Breakdown of academic impact, for papers by Alex Freire Sandes Breakdown of academic impact, for papers by Leonie Saft
Rankless by CCL
2026